factor-ix-complex and Novoseven Interactions

Interactions between factor-ix-complex(factor IX complex) and Novoseven (coagulation factor VIIa)

coagulation factor VIIa and factor IX complex (Moderate Drug-Drug)

GENERALLY AVOID: The risk of a potential interaction between coagulation factor VIIa and coagulation factor concentrates has not been adequately evaluated in preclinical or clinical studies. Theoretically, patients receiving concomitant therapy may have an increased risk of developing thrombotic events.

MANAGEMENT: Product labeling for coagulation factor VIIa recommends that simultaneous use of activated or nonactivated prothrombin complex concentrates be avoided.